Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: February 2013

Workgroups: Immunization and Infectious Diseases Workgroup

This resource is an update to the Advisory Committee on Immunization Practices recommendation that unvaccinated pregnant women get a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap). This update includes a recommendation that women get the vaccine during every pregnancy. The report also provides guidance for implementing the updated recommendations.

Read more about this resource

Objectives related to this resource (2)

Reduce cases of pertussis among infants — IID‑05
Target met or exceeded
Increase the proportion of women who get the Tdap vaccine during pregnancy — IID‑D01
Developmental

Suggested Citation

1.

Centers for Disease Control and Prevention. (2013) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6207a4.htm